1.

Relationship between long-term coffee consumption and components of the metabolic syndrome:the Amsterdam Growth and Health Longitudinal Study

2.

Relationship between long-term coffee consumption and components of the metabolic syndrome:the Amsterdam Growth and Health Longitudinal Study

3.

Relationship between long-term coffee consumption and components of the metabolic syndrome:the Amsterdam Growth and Health Longitudinal Study

4.

Relationship between long-term coffee consumption and components of the metabolic syndrome:the Amsterdam Growth and Health Longitudinal Study

5.

Relationship between long-term coffee consumption and components of the metabolic syndrome:the Amsterdam Growth and Health Longitudinal Study

6.

Relationship between long-term coffee consumption and components of the metabolic syndrome:the Amsterdam Growth and Health Longitudinal Study

1.

A novel foil flip-over system as the final layer in wound closure: Excellent cosmetic results and patient comfort

1.

A high level of fatigue among long-term survivors of non-hodgkin's lymphoma: Results from the longitudinal population-based PROFILES registry in the south of the Netherlands

2.

A high level of fatigue among long-term survivors of non-hodgkin's lymphoma: Results from the longitudinal population-based PROFILES registry in the south of the Netherlands

3.

A high level of fatigue among long-term survivors of non-hodgkin's lymphoma: Results from the longitudinal population-based PROFILES registry in the south of the Netherlands

4.

A high level of fatigue among long-term survivors of non-hodgkin's lymphoma: Results from the longitudinal population-based PROFILES registry in the south of the Netherlands

1.

What Could Influence Workers' Decisions to Disclose a Mental Illness at Work?

2.

What Could Influence Workers' Decisions to Disclose a Mental Illness at Work?

3.

What Could Influence Workers' Decisions to Disclose a Mental Illness at Work?

4.

What Could Influence Workers' Decisions to Disclose a Mental Illness at Work?

1.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

2.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

3.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

4.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

5.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

6.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

7.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

8.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

9.

Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces

1.

The Dutch Birth Centre Study: study design of a programmatic evaluation of the effect of birth centre care in the Netherlands

2.

The Dutch Birth Centre Study: study design of a programmatic evaluation of the effect of birth centre care in the Netherlands

3.

The Dutch Birth Centre Study: study design of a programmatic evaluation of the effect of birth centre care in the Netherlands

4.

The Dutch Birth Centre Study: study design of a programmatic evaluation of the effect of birth centre care in the Netherlands

5.

The Dutch Birth Centre Study: study design of a programmatic evaluation of the effect of birth centre care in the Netherlands

1.

Behavioral science around the world: volume III: public health

1.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

2.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

3.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

4.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

5.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

6.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

7.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

8.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

9.

Periodontal screening and referral behaviour of general dental practitioners in Flanders.

1.

Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients.

2.

Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients.

3.

Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients.

4.

Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients.

1.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

2.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

3.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

4.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

5.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

6.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

7.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

8.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

9.

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061